This brief communication highlights some observations that have raised the possibility that the oligosaccharides of glycoproteins may have roles as ligands or recognition structures in cell growth regulation. The initial experience with a new technology designed for investigating roles of glycoprotein oligosaccharides as recognition structures is also discussed.
Among the long awaited developments in modern cell biology is an understanding of the roles of the diverse oligosaccharide structures of glycoproteins, proteoglycans, and glycolipids and the significance of the pronounced changes that occur in their structures, proportions and patterning in embryogenesis, cell differentiation, and malignancy (1, 2) . Evidence is accumulating for the occurrence of numerous carbohydrate-recognizing proteins (lectins) among secreted, membrane-associated, cytosolic and nuclear proteins (3) . A role for lectin-oligosaccharide interactions in cell growth regulation is suggested, for example, by the observations (4) that the epidermal growth-factor receptor of A431 cells can be stimulated to autophosphorylate (a phenomenon associated with receptor activation) by perturbing its oligosaccharide chains with anti-carbohydrate antibodies. The role of lectin-oligosaccharide interactions in cell growth regulation is also suggested by the fact that the human and bovine receptor for insulinlike growth factor II is also a lectin with specificity for oligosaccharides containing 6-phosphorylated mannose (5,6). These observations, together with the knowledge that exogenously added plant lectins (e.g., phytohemagglutinin) are mitogenic for animal cells, have led us to suggest (4,7), as depicted in Figure  1 ., FIGURE 1. Diagram depicting part of a hypothetical growth-regulating network involving oligosaccharide recognition. The growthfactor receptor is shown here as a bifunctional glycoprotein (B) with a combining site for the growth factor and a lectinlike site for an oligosaccharide structure that occurs on a second growthregulatory glycoprotein (A). Reproduced with permission (2) .
there is inappropriate glycosylation as seen regularly in malignant cells. Studies of the involvement of glycoprotein oligosaccharides as recognition structures using the intact macromolecules are difficult to interpret for several reasons. First, a contribution of the protein moiety cannot always be excluded. Second, the multiplicity of oligosaccharide structures typically associated with a single glycoprotein means that it may not be feasible to define precisely the oligosaccharide species recognized. With these questions in mind, procedures are being developed (8, 9) A general strategy (13) for elucidating novel oligosaccharide recognition systems in a diversity of settings is presented in Figure 2 . The information thus gained could form the basis of novel drug designs variously targeted at tumor cell growth inhibition or the prevention of the initial stages of microbial infection. I have also proposed (13) that the neoglycolipid approach may be ideal for the quality control of the sugar chains of recombinant glycoproteins produced by molecular engineering for administration to man.
